A successful experimental model for intimal hyperplasia prevention using a resveratrol-delivering balloon
Open Access
- 23 October 2014
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 63 (3) , 788-794
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive diseaseJournal of Vascular Surgery, 2013
- Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelializationJournal of Controlled Release, 2012
- Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbitsJournal of Vascular Surgery, 2010
- Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by suppressing NF-κB activationArchives of Pharmacal Research, 2009
- Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosisHypertension Research, 2009
- Evolving Modalities for Femoropopliteal InterventionsJournal of Endovascular Therapy, 2009
- Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: role of NF-κB inhibitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantationJACC, 2003
- Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit modelLife Sciences, 2000
- Migration of smooth muscle and endothelial cells. Critical events in restenosis.Circulation, 1992